Ian B. Seiple

This paper introduces a ninhydrin-based warhead for selectively modifying arginine residues, enabling chemical proteomic studies and therapeutic targeting of reactive arginines.

This study identifies fragment-based inhibitors of VatD, an enzyme responsible for streptogramin resistance, using X-ray crystallography to guide inhibitor development.